HIV
Human Immunodeficiency Virus (HIV)
Overview
Acquired Immunodeficiency Syndrome (AIDS)
1-2% of every 1000 women giving birth are HIV+
Risk Factors
Multiple sexual partners
Unprotected vaginal/anal sex
Existing STI’s
Intravenous drug use
Unsafe injections, blood transfusions, tissue transplantation
Accidental needle stick injuries (especially among health workers)
SKIIIIIIPP
Characteristics of HIV
Type: Retrovirus (RNA: transfers to DNA via reverse transcription)
Key Proteins:
GP 41: Fusion with host cell membrane
GP 120: Attachment to target receptor
Target Cells
CD4(+) cells: T-Helper cells, Monocytes, Macrophages, Microglial cells, Dendritic cells
HEREEE NAAAAA
HIV and How It Works
HIV is a retrovirus, meaning it has RNA as its genetic material. Unlike human cells, which follow the normal process of DNA → RNA → Proteins, HIV reverses this process using a special enzyme called reverse transcriptase. It converts RNA → DNA, which is then used to produce new viruses. This process is called reverse transcription.
HIV Structure & Key Proteins:
Lipid bilayer (outer covering)
GP41 – Helps the virus fuse with human cells.
GP120 – Helps the virus attach to its target cells.
HIV Targets the Immune System:
HIV primarily infects CD4(+) cells, which are important for immunity. These include:
T-helper cells
Monocytes → Macrophages
Microglial cells (brain immune cells)
Dendritic cells (under the skin)
By attacking these cells, HIV weakens the immune system, making the body vulnerable to infections.
How HIV Infects Cells & Why It’s Hard to Cure
How HIV Enters the Body:
HIV attaches to CCR5 receptors on macrophages using its active site.
T-helper cells, which don’t have CCR5, use CXCR4 receptors instead.
GP41 helps the virus fuse with the host cell, allowing infection.
Why HIV is Hard to Cure:
HIV mutates rapidly, especially its GP120 protein, making vaccine development difficult (antigenic variation).
It takes about 7 years for HIV to develop into AIDS.
Some Northern Europeans have natural immunity due to a CCR5 mutation.
Key HIV Drugs:
Maraviroc blocks CCR5, preventing infection.
Enfuvirtide - destabilize/disrupts GP41, stopping fusion with cells.
HIV Structure & Key Enzymes:
Capsid (outer shell) – Made of p24 protein, a marker for HIV in blood tests.
HIV contains double RNA molecules and three key enzymes:
Reverse Transcriptase – Converts viral RNA into DNA.
Integrase – Merges viral DNA with the host cell’s DNA.
Protease – Cuts long viral proteins into functional parts.
HIV Types:
HIV-1 – Most common worldwide, highly transmissible.
HIV-2 – Found mainly in West Africa, less transmissible.
Mechanism of Infection
Virus contacts host cell
Utilizes CCR5 (on macrophages) and CXCR4 (on T-Helper cells) for attachment
Initiates fusion process
Development of AIDS
Takes approximately 7 years
Northern European race has natural immunity due to CCR5 mutation
Medication: Maraviroc (to inactive CCR5)
Challenges in Vaccine Development
Antigenic variation due to GP 120
Treatment
Enfuvirtide: destabilizes GP 41
HIV Types
HIV 1: Most common globally, highly transmissible
HIV 2: Primarily found in Western Africa
Important Facts
Anal sex poses the highest risk for HIV transmission.
The receptive partner (bottom) is at higher risk than the insertive partner (top).
Kissing is not a mode of transmission.
Use sterile equipment for tattoos and body piercings.